Skip to Main Content
Table 5—

FPG cutpoints equivalent to the WHO 2-h plasma glucose criterion of 200 mg/ dl

Study and referenceMethodFasting plasma glucose*
Pima Indians (129) ROC curves 123 mg/dl (6.8 mmol/l) 
Pima Indians (129) Equal prevalence 120 mg/dl (6.7 mmol/l) 
Several Pacific populations (134) Equal prevalence 126 mg/dl (7.0 mmol/l) 
NHANES III§ Equal prevalence 121 mg/dl (6.7 mmol/l) 
Study and referenceMethodFasting plasma glucose*
Pima Indians (129) ROC curves 123 mg/dl (6.8 mmol/l) 
Pima Indians (129) Equal prevalence 120 mg/dl (6.7 mmol/l) 
Several Pacific populations (134) Equal prevalence 126 mg/dl (7.0 mmol/l) 
NHANES III§ Equal prevalence 121 mg/dl (6.7 mmol/l) 
*

The results for the receiver-operating characteristics (ROC) curve analysis of the Pima Indian data and those from the Pacific populations appear in the cited publications (in millimoles per liter). The other results have not been published;

equivalent to the WHO criterion of 2-h PG ≥200 mg/dl (11.1 mmol/l) in sensitivity and specificity for retinopathy from analysis of ROC curves;

the method is described by Finch et al. (134);

§

NHANES III subjects aged 40–74 years, excluding users of insulin and oral hypoglycemic agents, weighted according to sampling plan (K. Flegal, National Center for Health Statistics, personal communication).

Close Modal

or Create an Account

Close Modal
Close Modal